Close

Blueprint Medicines (BPMC) PT Lowered to $100 at Wedbush, After Trial Misses Endpoints

April 28, 2020 2:31 PM EDT Send to a Friend
Wedbush analyst David Nierengarten lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login